Pharmaceuticals

BioMed refinancing lab-property debt in proposed $2B CMBS offering

The Blackstone-affiliated company recently took out a cash-out refi mortgage for a 17-property portfolio, an opportunity aided by high demand for its R&D facilities for COVID-19 research.

By Glen Fest

March 17

Esoteric ABS

DRI Capital to issue another $100M of pharmaceutical royalty ABS

The bonds will be collateralized by payments from 15 royalty streams on 14 patent-protected drugs and technologies and will rank pari passu with securities issued from the same master trust in 2017.

By Glen Fest

November 28